Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits RAHWAY, N.J., July 9, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of the aqua business of […]
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease RAHWAY, N.J., June 25, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Department of Agriculture (USDA) approval of NOBIVAC® […]
New scanning technology enhances Standardbred industry’s pioneering approach to equine identification and monitoring RAHWAY, N.J., June 18, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is pleased to recognize a 50,000-microchip milestone as part of […]
First-of-its-kind line of vaccines leverages state-of-the-art RNA-particle technology to protect cats and dogs from rabies RAHWAY, N.J., June 17, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch and availability of the […]
RAHWAY, N.J., June 4, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of more than 30 studies at the 27th International Pig Veterinary Society Congress (IVPS) and 15th European Symposium of […]
First centrally registered vaccine in the European Union against the currently circulating avian influenza virus strains of clade 2.3.4.4b RAHWAY, N.J., May 24, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the […]
Data Presented at the World Buiatrics Congress 2024 RAHWAY, N.J., May 21, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced findings on the global economic impact of parasites in cattle, concluding that parasite […]
Rahway, NJ, May 13, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the ruminant health at the World Buiatrics Congress 2024, May 20-24 […]
If approved by the European Commission, the vaccine will become an available tool for governments to consider as part of a holistic strategy to combat the spread of highly pathogenic avian influenza (HPAI) which may include additional vaccinations plus enhanced biosecurity and surveillance Potentially the first centrally registered vaccine in the European Union against the […]
Award to Recognize Three Cutting-Edge Organizations, Startups or Individuals who Promote a Positive Change in the Swine Industry Award Accepting Nominations Through June 30, 2024 RAHWAY, N.J., April 5, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA […]